By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Select your region

To ensure that the content you receive is tailored to your region, please select your location from the available options. By doing so, we will be able to provide you with information pertaining to products and services that are specific to your region. This will enable us to better meet your needs and ensure that you receive the best experience possible.

Ankyras
Clinical Research & Publications

ANKYRAS
Neurovascular
Modification of Woven Endo-Bridge After Intracranial Aneurysm Treatment: A Methodology for Three-Dimensional Analysis of Shape and Relative Position Changes

Purpose: During follow-up of patients treated with WEB devices, shape changes have been observed. The quantitative three-dimensional measurement of the WEB shape modification (WSM) would offer useful information to be studied in association with the anatomical results and try to better understand mechanisms implicated in this modification phenomenon.

Ann Biomed Eng 52, 1403–1414 (2024). https://doi.org/10.1007/s10439-024-03465-5
February 24, 2024
ANKYRAS
Neurovascular
Cerebral Aneurysm Occlusion at 12-Month Follow-Up After Flow-Diverter Treatment: Statistical Modeling for V&V With Real-World Data

Flow-Diverter (FD) porosity has been pointed as a critical factor in the occlusion of cerebral aneurysms after treatment. Objective: Verification and Validation of computational models in terms of predictive capacity, relating FD porosity and occlusion after cerebral aneurysms treatment.

Front Med Technol . 2021 Sep 17;3:705003
ANKYRAS
Neurovascular
Early Results in Flow Diverter Sizing by Computational Simulation: Quantification of Size Change and Simulation Error Assessment

Sizing of flow diverters (FDs) stent in the treatment of intracranial aneurysms is a challenging task due to the change of stent length after implantation

Oper Neurosurg (Hagerstown) . 2018 Nov 1;15(5):557-566.

Learn more or request a product demonstration

We are here to guide and help you find the solution that is the best fit for your unique needs. Fill in the form to connect with us and a suitable solution expert will get back to you as soon as possible

Rambla Catalunya 53, 4-H, 08007, Barcelona, Spain.

+34 933 28 39 64

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Disclaimer & Regulatory Information

Ankyras is manufactured by Mentice Spain S.L.
ANKYRAS is intended to be used by physicians trained in medical procedures involving percutaneous and intravascular interventions.
Ankyras is 510(k) cleared by FDA.

Mentice Spain SL: Mentice Spain SL has obtained the ISO 13485 certification with number MD 784027
Ankyras certifications: The Ankyras product complies with the Medical Device Regulation (EU CE Mark, MDR 784032) and the UK Conformity Assessed (UKCA 784033)